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ABSTRACT Blood cell development in the Drosophila lymph gland is controlled by multiple factors, most
of them conserved from ﬂies to mammals. The Drosophila homolog of vertebrate PDCD2, Zfrp8, is required
in Drosophila hematopoietic stem cell development. Zfrp8 mutant larvae show a disruption of homeostasis
in the lymph gland and vast lymph gland overgrowth. The loss of one copy of Zfrp8 also causes a lymph
gland enlargement. This dominant phenotype can be modiﬁed by heterozygous mutations in cell-cycle
genes and several genes functioning in blood development. To identify additional genes that function in
hematopoiesis, we screened a collection of second and third chromosome deﬁciencies for modiﬁers of
Zfrp8 heterozygous phenotype. Using deﬁciency mapping, available single gene mutations, and RNAi lines,
we identiﬁed several novel factors required for lymph gland development and hemocyte differentiation.
Distinct lymph gland phenotypes of nine of these genes are reported here for the ﬁrst time. Importantly, the
orthologs of four of them have a role in mammalian blood development and leukemogenesis. Our work has
shown that the number of genes regulating normal blood cell development in Drosophila is much larger
than expected, and that the complex molecular mechanisms regulating hemocyte differentiation are com-
parable to those in vertebrates.
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In vertebrates, hematopoietic stem cells (HSC) give rise to at least eight
hematopoietic lineages. Studies of signaling pathways and transcrip-
tion factors revealed a number of factors controlling decision points in
hematopoiesis. The differentiation along each lineage is orchestrated
by transcription regulators, including PU.1, Foxo1, EBF1, Runx, and
GATA factors. Notch, JAK/STAT, and Wingless (Wg) signaling are
implicated in regulation of self-renewal [reviewed in Mercer et al.
(2011) and Orkin and Zon (2008)]. Modern genomic approaches
uncovered many more genes expressed during blood cell differentia-
tion and identiﬁed regulatory networks involving hundreds of tran-
scription factors (Novershtern et al. 2011). Although the role of
transcriptional control in hematopoiesis cannot be underestimated,
pre- and posttranscriptional mechanisms also play important roles
in hematopoiesis, but only few examples have been studied (Baou
et al. 2011; Sardina et al. 2011; Yoshida et al. 2011).
Hematopoiesis in Drosophila is simpler than in vertebrates and
results in the differentiation of three major types of hemocytes: plas-
matocytes, crystal cells, and lamellocytes [for review see (Crozatier
and Meister 2007; Evans and Banerjee 2003; Lanot et al. 2001; Leb-
estky et al. 2000]. Like in humans, the best-characterized genes in
Drosophila hematopoiesis are transcription factors and genes encod-
ing components of signal transduction pathways. For example the
transcription factor lozenge (Lz), a Runx domain protein, is required
for crystal cell speciﬁcation, and the GATA transcription factor pan-
nier (Pnr) is essential for plasmatocyte development (Lebestky et al.
2000; Minakhina et al. 2011). Jak/Stat signaling controls several pro-
cesses, including both plasmatocyte and lamellocyte differentiation
(Luo et al. 2002; Minakhina et al. 2011). The Wingless (Wg), Hedge-
hog (Hh), and Notch pathways also function at several stages of
lymph gland development (Mandal et al. 2007; Mukherjee et al.
2011; Muratoglu et al. 2006; Sinenko et al. 2009; Tokusumi et al.
2010). Recent studies by Avet-Rochex et al. (2010) suggest that
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Volume 2 | March 2012 | 393hemocyte differentiation relies on diverse cellular mechanisms, but
genes other than transcription factors are not well studied in verte-
brates and invertebrate models.
Drosophila lymph gland structure and development
In Drosophila, the lymph gland is the major source of adult hemocytes
and has been developed as a model to study hematopoiesis. The
lymph gland is established during embryogenesis as paired clusters
of cells associated with the cardiovascular system, alongside the dorsal
vessel (Jung et al. 2005; Mandal et al. 2004). Clonal analysis shows that
embryonic and ﬁrst-instar lymph glands contain pluripotent cells with
the ability to form cell lineages, reminiscent of vertebrate HSCs
(Minakhina and Steward 2010). After the transition to the second-
instar larval stage, the pluripotency is no longer observed (Krzemien
et al. 2010). During the second- and third-instar larval stages, the
lymph glands expand and form primary lobes and a series of sec-
ondary and tertiary lobes located posterior to the primary lobes
alongside the dorsal vessel (Figure 1A). At the third-instar stage,
the primary lobe can be subdivided into three structurally distinct
compartments: the medullary zone (MZ), with tightly packed cells
located proximally to the dorsal vessel; the petal-shaped distal cor-
tical zone (CZ); with larger and more loosely packed cells; and
a hematopoietic niche, the posterior signaling center (PSC; Figure
1, B and C) (Jung et al. 2005; Krzemien et al. 2007; Lebestky et al.
2003; Mandal et al. 2007).
By the middle of third instar, MZ cells become quiescent, while the
cells in the CZ keep proliferating and the CZ expands till pupariation
(Jung et al. 2005; Krzemien et al. 2010; Minakhina et al. 2011). The
CZ contains hemocytes at different stages of differentiation. The ma-
jority of these cells are called intermediate progenitor cells (Krzemien
et al. 2010) or CZ prohemocytes (Minakhina et al. 2011) (Figure 1,
yellow). These cells express the intermediate marker, peroxidasin
(Pxn), do not express terminal differentiation markers, and are able
to proliferate (Jung et al. 2005; Krzemien et al. 2010; Nelson et al.
1994). During the late third instar and metamorphosis, hemocytes
mature into plasmatocytes, crystal cells, and lamellocytes, and they
are released into circulation (Grigorian et al. 2011) (Figure 1, C–E). In
normal, unchallenged larvae, the maturation of CZ prohemocytes into
plasmatocytes, the predominant blood cell type, starts at middle-to-
late third instar at the surface of the CZ (Figures 1C and 2, A, A9,a n d
F) and culminates at pupariation (Grigorian et al. 2011; Jung et al.
2005; Kurucz et al. 2007a,b; Minakhina et al. 2011). Crystal cells are
seen in a scattered pattern throughout the CZ (Figures 1, 2, and 6).
The third type of Drosophila blood cells, the large and ﬂat lamellocyte,
is rare in normal lymph glands. Upon immune challenge, the numbers
of mature plasmatocytes as well as lamellocytes increase substantially,
and the lymph gland often disintegrates before pupariation (Figure 1,
D and E) (Markus et al. 2009; Rizki and Rizki 1992; Sorrentino et al.
2002).
Identiﬁcation of genes controlling
normal hematopoiesis
Recently we reported a novel conserved factor, Zfrp8, that functions in
Drosophila hematopoiesis. Zfrp8 mutants show a loss of the MZ-CZ
organization and vast overproliferation of CZ prohemocytes, leading
to an increase in all three types of hemocytes, particularly lamellocytes
(Minakhina et al. 2007; Minakhina and Steward 2010). In Zfrp8 het-
erozygous animals, the size of the lymph gland is 2–2.5 times enlarged.
Using clonal analysis, we showed that Zfrp8 is required in early lymph
gland development for the viability or division of HSCs and that the
lack of Zfrp8 does not cause cell-autonomous overproliferation (Min-
akhina and Steward 2010). Therefore, loss of one or both copies of
Zfrp8 changes the homeostasis within the lymph gland and causes
overproliferation of hemocytes at intermediate stages of differentiation
in noncell autonomous manner.
Previously we showed that the Zfrp8null/+ lymph gland phenotype
can be modiﬁed by dose reduction of genes that control cell prolifer-
ation and by genes functioning in hemocyte development (Minakhina
et al. 2007, 2011). We identiﬁed two enhancers, Dgrip91, which in-
volved in anchoring gamma-Tubulin to the centrosome, and Cdc27,
Figure 1 Schematic representation of the lymph gland structure. (A) Whole lymph gland with primary and secondary lobes. (B–C) Cross-sections
and z-sections of normal primary lobe of middle (B) and late (C) third-instar larval lymph glands. MZ prohemocytes expressing dome-GAL4 are
shown in green. Prohemocytes expressing no markers are blue. CZ prohemocytes expressing Pxn are shown in yellow, crystal cells are purple, and
lamellocytes are elongated red cells. Plasmatocytes (encircled in red) ﬁrst differentiate at the surface of the CZ. (D, E) Primary lobes disintegrate
upon metamorphosis or in response to immune challenge. Disintegration is also observed in a number of mutants as a result of accelerated
hemocyte differentiation. (F, G) Examples of abnormally shaped primary lobes observed during the screen. Markers and their expression used in
this study are indicated below the drawing.
394 | K. Li Tan, et al.n Table 1 Summary of the screen for genetic modiﬁers of Zfrp8/+ lymph gland phenotype
Deﬁciency Modifying
Zfrp8/+ Lymph
Gland Overgrowth
Deleted
Segment, Cytology
Numbers of Lymph
Glands with Phenotype/
Total Analyzed
Comment on
Mapping
Modifying Alleles and
RNAi Lines
Suppressing
Df(2L)BSC31 23E5–23F5 7/13 Smaller deﬁciencies tested,
no modiﬁers found.
n/i
Df(2L)BSC17 30C3–30F1 14/14 Mapped to 30C1 and
30C5. Two dominant
suppressors identiﬁed.
pelo1, hoipk07104
Df(2R)cn9 42E–44C1 20/27 Not mapped. n/i
Df(2R)BSC29 45D3–45F6 7/12 Mapped to 45F5–46A1. CG30338 {v 29189}
Df(2R)en-A 47D3–48B2 6/11 Not mapped. n/i
Df2R)BSC11 50E6–51E4 10/10 Mapped to 51A5—51C1. n/i
Df(2R)PC4 55A1–55F2 9/10 Mapped to 55B11–55C9. nopo {v104477} Idgf5 {v100977}
Df(2R)BSC22 56D7–56F12 10/19 Not mapped. n/i
Df(2R)vir130 59B1–59E1 17/17 Smaller deﬁciencies tested,
no modiﬁers found.
n/i
Df(2R)or-Br6 59D5–60B8 13/24 Weak modiﬁer mapped to 59D9. CG30415EY04039
Df(2R)M60E 60E6–60E11 20/21 Not mapped.
Df(3L)BSC23 62E8–63B6 8/12 Not mapped.
Df(3L)AC1 67A2–67D13 10/14 Two dominant suppressors
identiﬁed.
shcKG06847, vs.g EY05552,
MTF-1 {v107124}
Df(3L)Pc-2q 78C5–79A1 9/15 Not mapped. n/i
Df(3R)mbc-30 95A5–95C11 9/10 Mapped to 95B1–95D1. n/i
Modifying Phenotype of trans-heterozygous
lymph glands. Comment
on mapping.
Df(2L)net-PMF 21A1–21B8 9/12 Small CZ. Both enhancer and
suppressor are found.
l(2)gl4, smo3
Df(2R)Egfr5 57D2–58D1 9/9 Small lymph gland with changed
morphology. Not mapped.
n/i
Df(3L)emc-E12 61A–61D3 21/28 Lymph glands are enlarged and
disintegrated. Enhancing region
mapped to 61A5–61B1 and
one suppressing gene
mapped to 61B1.
Pk61CEP3091, Pk61C5,
Df(3L)W10 75A6–75C2 lethal Smaller deﬁciencies do not show
lethality. Enhancing region
is mapped to 74D1–75B11
Enhancer and
suppressors found.
Eip75BA81, Adgf-Ad11616,
mus304D3, n/i
Df(3L)BSC249 79B2–79D1 11/11 Disintegrated primary lobes.
Not mapped.
n/i
Df(3R)ME15 81F3–82F7 14/14 Disintegrated primary lobes.
Not mapped.
n/i
Zfrp8-independent
phenotypes
Lymph gland phenotype
of deﬁciency/+
Comment
Df(2L)ast2 21D1–22B3 15/15 Lymph gland disintegration
mapped to 21D4-21E2.
Ush, lwr are known to cause
hematopoietic phenotype
Df(2L)c144 22F4–23C3 15/17 Increased size and
differentiation.
Df(2L)spdj2 27B2–27F2 10/10 Decreased size
and small CZ.
Df(2R)cn9 42E–44C1 27/27 Decreased size, increased
differentiation.
Df(2L)TW161 38A6–40B1 8/11 Decreased size, increased
differentiation.
(continued)
Volume 2 March 2012 | Hematopoietic Genes in Drosophila | 395which is a component of the anaphase-promoting complex (APC). The
GATA factor gene pannier (pnr)w a si d e n t i ﬁed as a suppressor of
Zfrp8null/+ and Zfrp8null/Zfrp8null lymph gland overgrowth (Minakhina
et al. 2007). Further studies have shown that pnr is required for plas-
matocyte differentiation and that the balance between the two Pnr
isoforms, Pnr a and b, controls hemocyte proliferation (Minakhina
et al. 2011). This ﬁnding suggested that Zfrp8null/+ lymph gland over-
growth may be manipulated by changes in cell proliferation as well as
differentiation.
We performed a genetic deﬁciency screen designed to identify
modiﬁers of the dominant Zfrp8null/+ lymph gland phenotype. We
found 21 deﬁciencies that altered the phenotype. Further analysis of 9
of these deﬁciencies identiﬁed 11 suppressors and four enhancers of
Zfrp8null/+ lymph gland overgrowth. Two of the enhancers, mutagen-
sensitive 304 (mus304) and no poles (nopo) are reported regulators of
the cell cycle. The genes suppressing Zfrp8 overgrowth mostly con-
trolled plasmatocyte differentiation and changed the homeostasis be-
tween prohemocytes and mature blood cells.
The large number of deﬁciencies and new genes identiﬁed suggest
that our screen is far from saturated and that only a small portion of
the genes functioning in Drosophila hematopoiesis are known so far.
We describe the hematopoietic phenotypes of 10 genes. Of these, 9
genes were not previously reported to function in Drosophila hema-
topoiesis, and 4 of them have mammalian orthologs with a role in
blood development and leukemogenesis. Thus, hematopoiesis in ﬂies
is more complex than previously demonstrated, and in its complexity
it is even more similar to blood formation in vertebrates.
MATERIALS AND METHODS
Drosophila strains, collection of larvae, and Zfrp8
genetic interactions
Zfrp8Df(2R)SM206 was used as the Zfrp8null allele (Minakhina et al. 2007;
Minakhina and Steward 2010). Fly stocks bearing the mutations
nopoZ1447 and noponull (nopoExc142) were kindly provided by Dr. L.
A. Lee (Vanderbilt University, Nashville, TN); and pxn-GAL4 and 2x-
UASGFP by Dr. U. Banerjee (University of California, Los Angeles,
CA). Collection of deﬁciencies uncovering the second and third chro-
mosomes of the genome, drivers, balancer stocks, smaller deﬁciencies,
mutant alleles, and P-element insertions were obtained from the Bloo-
mington Drosophila Stock Center (Bloomington, IN). UAS-dsRNA
(RNAi) transgenic lines were obtained from the Vienna Drosophila
Resource Center (VDRC) and the Bloomington Drosophila Stock
Center (TRiP lines) (Dietzl et al. 2007; Ni et al. 2011). Deﬁciencies,
mutant alleles, and RNAi lines are listed in Tables 1 and 2 and Table
S1. tub-Gal4 UAS-dcr2/TM6b was used for strong general gene knock-
down, and dome-GAL4/FM7, UAS-cd8GFP was used for MZ visuali-
zation and knockdown in the MZ. T(2;3)B3, CyO;TM6B Tb1, GlaBC,
and GFP-marked balancer chromosomes were used to identify mutant
larvae. w118, driver/+,a n dUAS-RNAi animals were used as wild-type
controls.
Larvae were grown on standard cornmeal/molasses food at 25 
until they reached the third-instar larval stage. Late third-instar larvae
were collected 6–12 hr before pupariation. Middle third-instar larvae
were collected 24–36 hours before pupariation. Mutant larvae that
failed to pupate were timed according to the development of their
heterozygous siblings. Gut color, mouth hook and spiracle morphol-
ogy, and the size and morphology of the brain and discs served as
additional controls for developmental staging.
The genetic screen was based on the mild haplo-insufﬁcient
phenotype of Zfrp8null/+ larvae. The lymph gland of Zfrp8null/+ larvae
is on average twice (2.1; SD = 0.2) as large as that of wild type. Second
and third chromosome deﬁciencies were crossed to T(2;3)B3, CyO;
TM6B, Tb1 balancers and then crossed with Zfrp8null /T(2;3)B3, CyO.
From each cross, 10–30 trans-heterozygous, non-Tb larvae at the late
third-instar stage were dissected, the area of 2D images of sample
lymph glands were measured using Adobe PhotoShop and normalized
to the size of the wild-type gland as previously described (Minakhina
et al. 2007).
Immunochemistry and imaging
Larval lymph glands were dissected, ﬁxed, immunostained, and
analyzed as described previously (Jung et al. 2005; Minakhina and
Steward 2010; Minakhina et al. 2011). Antibodies speciﬁc for plasma-
tocytes (P1, 1:400 dilution; from Dr. I. Ando, Biological Research
Center, Szeged, Hungary); rabbit anti-PPO2 antibody (1:2000; from
Dr. G. Christophides, Imperial College, London); rabbit anti-Pxn an-
tibody (1:700; from Drs. John Fessler and Sergey Sinenko, UCLA); and
anti-Antp antibody (1:20; from Glicksman and D. Brower, Develop-
mental Studies Hybridoma Bank, University of Iowa, Iowa City, IA)
were used as plasmatocyte, crystal cells, CZ prohemocyte, and PSC
markers, respectively (Christophides et al. 2002; Kurucz et al. 2007a, b;
Nelson et al. 1994). Alexa Fluor 488 phalloidin (Invitrogen, Carlsbad,
CA) was used to visualize cell shape and detect lamellocytes. Second-
ary goat anti-mouse Cy3 and goat anti-rabbit Cy5 (Jackson Immu-
noResearch Laboratories, West Grove, PA) were used at 1:500. DNA
was stained using Hoechst 33258 (Invitrogen, Carlsbad, CA). Samples
were mounted in Vectashield (Vector Laboratories, Burlingame, CA)
and examined with a Zeiss Axioplan-2 microscope. Images were cap-
tured using a Leica DM IRBE laser scanning confocal microscope
(objectives 40· and 63· oil), analyzed with Leica Microsystems soft-
ware, and further processed using Adobe PhotoShop.
RESULTS
To ﬁnd genetic interactors of Zfrp8 and identify novel genes function-
ing in hematopoiesis, we performed a dominant modiﬁer screen. We
n Table 1, Continued
Deﬁciency Modifying
Zfrp8/+ Lymph
Gland Overgrowth
Deleted
Segment, Cytology
Numbers of Lymph
Glands with Phenotype/
Total Analyzed
Comment on
Mapping
Modifying Alleles and
RNAi Lines
Df(3L)XG5 71C2–72C1 19/19 Enlarged cortex.
Df(3R)BSC38 85F1–86C8 6/10 Enlarged.
Df(3R)T-32 86D9–87C4 13/17 Enlarged disintegrated.
Df(3R)ea 88E7–89A1 18/18 Enlarged disintegrated.
Df(3R)crb87-5 95F8–96A20 20/20 Primary lobe enlargement.
Columns 1 and 2 show the deﬁciencies that modify the Zfrp8null/+ phenotype in more than 50% of the lymph glands and their cytological location. Column 3 shows
the number of lymph glands with modiﬁed phenotypes relative to the total number analyzed. Column 4 shows the smallest cytological interval to which the modifying
effect was mapped. Column 5 lists the genes that were found to have modifying effect. n/i, modifying genes were not identiﬁed.
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whose lymph glands are 2.1 (SD = 0.2) times larger than wild type,
and a series of chromosomal deﬁciency lines (Bloomington Drosoph-
ila Stock Center) that uncover more than half of the genome. Two-
hundred eighty-eight second and third chromosomal deﬁciencies (Ta-
ble 1 and Table S1) were crossed with Zfrp8null/T(2:3)Cy, Tb to obtain
Df +/+ Zfrp8null or Zfrp8null/+, Df/+ larvae. Then 10–30 trans-hetero-
zygous late third-instar larvae from each cross were dissected and the
size of the lymph glands assessed [see Materials and Methods and
Minakhina et al. (2007)]. When more than half of the lymph glands
were in the range of 0.8–1.2 times the size of the wild-type gland
(average size of all glands 1–1.3; SD , 0.3), the deﬁciency was clas-
siﬁed as a strong suppressor (Table 1). Weak modiﬁers that altered the
average size of the Zfrp8/+ lymph gland in fewer than half of the
animals and showed variations in shape or size are listed in Table
S1. The majority of deﬁciencies tested (190) in trans to Zfrp8null show
no difference from Zfrp8null /+ lymph gland phenotype (Table S1).
We identiﬁed 18 deﬁciencies that strongly suppress the Zfrp8null /+
lymph gland overgrowth. The morphology of the lymph gland of these
heterozygous deﬁciencies was also analyzed in a Zfrp8+ background.
T h r e ed e l e t i o n sp r o d u c e ds m a l l e rl y m p hg l a n d st h a nn o r m a li nh e t e r o -
zygous animals (“Zfrp8-independent phenotypes”; Table 1). The other 15
deletions caused no or a moderate enlargement (from 1.2 to 1.7 the wild-
type size) of the lymph gland (see “Suppressing” in Table 1, column 1).
n Table 2 Alleles and RNAi lines tested for modiﬁcation of Zfrp8null/+ lymph gland phenotype
Genomic Region Number of Annotated Genes Tested Alleles Tested RNAi Lines
21A1–21B8 50 kis1
spen3
smo3
l(2)gl4
NheDP01088
mbm {v18699}
CG17075 {v103741}
CG33635 {v48812}
CG11604 {v18699}
30C1 5 GlcAT-S {v42779}
Trx2 {v104629},
30C5 6 pelo1
hoipk07104
Pka-C1DN
45F5–46A1 16 updoKG01041
mmp2k00604
Map60KG00506
Not1 {JF01135}
RpL31{v104467}
CG30338 {v29189}
CG30340 {v100088}
51A5–51C1 30 Tra2B
ttv00681b
ttvG00158
Sec61b07214
Uhg5EY04055
Sec61b {v107784}
Su(var)2-HP2 {JF01994}
M-spondin {v107608}
CG12858 {v1688}
55B11–55C9 60 OteB279
lolalk02512
sbbBG01610
Dp1BG02288
imdBG02288
fjdl
nopo {v104477}
lolal {JF01419}
pen-2 {JF02608}
sbb {JF02375}
Idgf5 {v100977}
59D9 9 CG13551e03979
CG30415EY04039
61A5–61D3 130 Pk61CEP3091
CG13887EY2104
thoc7G4736
CG16940G4736
NitFhit {v27830}
pyx {JF01242},
CG13887 {v106452}
mri {JF01921}
67A2–67D13 150 ShcKG06847
Uch-L3j2B8
phol81A
vsgEY05552
vsgEY05552
fry7
nbs1
RpS174
NF-YAKG06786
CG13887EY21004
MTF-1 {v107124}
CG3911, {21738}
NF-YA {JF02013}
LanB2 {v104013}
CG33696 {v101076}
CG16719 {102653}
CG18177 {101408}
74D1–75B11 90 Eip75BD51
Adgf-Ad11616
mus304D3
mus304D1
NUCB1c01508
CG5589f06152
Seventy genes from 10 genomic regions were tested for their ability to modify the Zfrp8/+ lymph gland phenotype. Column 2 shows the approximate number of
annotated genes in each region. Columns 3 and 4 show the alleles and RNAi lines tested for modifying effect. The ID of each RNAi line is shown in braces.
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Zfrp8null/+ lymph glands (more than half of the glands show severe
reproducible changes). These changes included loss of the petal-
shaped CZ (Figure 1F), altered CZ shapes (Figure 1G), lymph gland
disintegration (Figure 1, D and E), and primary or secondary lobe
enlargement. When crossed to wild type, 7 of them showed the same
morphological changes as observed in trans to Zfrp8 and were placed
into the “Zfrp8-independent” group (Table 1). The other 6 deﬁciencies
showed a phenotype only in trans to Zfrp8null and showed normal
morphology in a wild-type background. They formed a group called
“modifying deﬁciencies” (Table 1). This group also included Df(3L)
W10, which caused lethality of trans-heterozygotes (Zfrp8null/+,
Df(3L)W10/+).
Smaller and partially overlapping deﬁciencies in 12 of the 32
chromosomal regions were checked for their ability to modify the
Zfrp8null/+ phenotype. Smaller deletions in regions 23E–23F and 59B–
59E showed no phenotypic change in trans to Zfrp8null.F r o mt h e
other 10 chromosomal regions, each uncovering from 5 to 150 genes,
we chose 41 genes that had available mutant alleles (Table 2). Priority
was given to genes that did not have an established function in Dro-
sophila hematopoiesis. Lymph glands of trans-heterozygous Zfrp8null
larvae were scored as above. Smaller deﬁciencies uncovering the seg-
ment deleted in Df(3L)W10 did not allow us to identify the region
responsible for the lethality. However, one of the deletions, Df(3L)
ED4710, showed enlargement of the Zfrp8null/+ lymph gland: 9 of
16 lymph glands were 3.5 to 4 times larger than wild type.
Dominant suppressors of Zfrp8 regulate
hemocyte differentiation
The screen for dominant modiﬁers identiﬁed both known and novel
genes involved in Drosophila hematopoiesis and immunity. For ex-
ample, smoothened (smo)a n dadenosine deaminase growth factor
(Adgf-A) were known to function in the development of hemocytes,
and signal peptide protease (spp) is known to regulate Drosophila
immunity (Dolezal et al. 2005; Junell et al. 2007; Tokusumi et al.
2010). But the nine genes [pelota (pelo), hoi-polloi (hoip), mutagen-
sensitive 304 (mus304), SHC-adaptor protein (Shc), visgun (vsg), phos-
phoinositide-dependent protein kinase 1 (Pdk1)/Pk61C, ecdysone-in-
duced protein 75B (Eip75B), CG30415,a n dlethal (2) giant larvae
(l(2)gl)] did not have an established function in hematopoiesis. To
determine a possible hematopoietic function of these genes, we analyzed
the lymph gland phenotypes of homozygous mutant larvae at early
Figure 2 Lymph gland phenotypes of Zfrp8null/+ overgrowth suppressors. (A–E, A9–E9) Confocal projections of middle third-instar larval lymph
glands. Lymph gland primary lobes are outlined by white dotted line. Normal wild-type glands have few or no plasmatocytes (P1, membrane
marker, red A, A9). The number of plasmatocytes in Agdf-Ad11616, vs.gBG00708, and ShcK66847 homozygous mutants (B–D, B9–D9) is drastically
increased, compared with that in wild-type (A, A9). PSCs are stained with anti-Antp (nuclear, red). Red channel (Antp and P1) for each projection is
shown in (A9–E9). Crystal cells are stained with anti-PPO (cytoplasmic marker, pink). Primary lobes are outlined with white dotted line. Secondary
lobes (SL) in (A–D) do not express differentiation markers. (F–J) Confocal cross-sections through the inner layers of late third-instar larval lymph
glands. The border between MZ and CZ is shown by yellow dotted line. (F) In wild-type larvae, plasmatocyte maturation is seen in the surface
layers (P1, membrane marker, red) of the CZ. Agdf-Ad11616 and vsgEY05552 lymph glands show plasmatocyte differentiation across all CZ layers and
also a signiﬁcant reduction of MZ size (J, H). (I) CG30415EY040039 caused an increase in plasmatocytes, disintegration of the primary lobes, and
enlargement and increased differentiation of secondary lobes. The prospective positions of primary lobes (white dotted outline) were identiﬁed
by the presence of the PSCs (anti-Antp, nuclear red, rectangular inset). (E, E9,J )l(2)gl4/Df(2L)net62 causes lymph gland overgrowth with relatively
weak staining for P1 at the surface of the lobes. Staining with phalloidin (green in F–J) shows cell shape allowing detection of lamellocytes and
strongly stains heart tube. DNA is shown in blue. Scale bars are 10 mm.
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hemocyte maturation. We used P1 antibody staining the plasmatocyte-
speciﬁc protein Nimrod C1 (Kurucz et al. 2007a), anti-Pro-phenoloxidase
for crystal cells (Christophides et al. 2002; De Gregorio et al. 2002),
phalloidin to reveal the shape of lamellocytes, and anti-Pxn to deﬁne
the CZ (Figures 2–4) (Jung et al. 2005; Nelson et al. 1994). Homo-
zygotes of the suppressing genes hoip (hoipk07104)a n dPdk1/Pk61C
(Pk61CEP3091) showed early lethality and were excluded from this anal-
ysis. Lymph glands of middle and late third-instar Adgf-A, vsg, shc,
and CG30415 homozygous larvae were compared with wild-type
lymph glands at similar stages of development (Figure 2).
During normal development, the crystal cells can be detected in
the CZ throughout the third-instar larval stages. Lamellocytes are only
occasionally seen in late third-instar larval lymph glands. The Nimrod
C1 (P1)-positive plasmatocytes are not seen in the lymph glands until
the middle of third instar. During late third-instar larval development,
plasmatocyte differentiation starts on the surface of the CZ, whereas
the hemocytes in the inner layers of the CZ differentiate later during
metamorphosis (Figures 1C and 2F) (Grigorian et al. 2011; Minakhina
et al. 2011).
Adgf-A controls deamination of adenosine and deoxyadenosine.
Complete loss of Adgf-A causes a dramatic increase in levels of aden-
osine and deoxyadenosine in larval hemolymph. It also leads to in-
creased numbers of circulating hemocytes, disintegration of the lymph
gland primary lobe, a large number of cells with characteristics of
plasmatocytes and macrophages, and larval death (Dolezal et al.
2005). We found that a hypomorphic allele, Adgf-Ad11616, caused by
a P-element insertion into the ﬁrst intron, did not affect viability but
caused a strong hematopoietic phenotype (Figure 2, B, B9, and G).
Plasmatocyte differentiation starts prematurely in early third-instar
larvae, and by the late third-instar stage, the majority of cortical pro-
hemocytes, including the hemocytes in the inner layers of the gland,
were positive for the plasmatocyte marker. The size of the medulla was
signiﬁcantly reduced compared with wild type (Figure 2G).
Vsg is an ortholog of mammalian sialomucin endolyn (CD164), an
adhesion receptor protein that regulates the adhesion of CD34+ stem
or precursor cells to bone marrow stroma and the recruitment of
CD34+ cells into mitosis (Chan et al. 2001; Forde et al. 2007). In
Drosophila, all existing loss of function alleles are homozygous viable.
Although ablation of Vsg inhibits proliferation in S2 cells and loss-of-
function mutations cause some reduction in embryonic viability, it
seems otherwise not to be required for animal development and fe-
cundity (Zhou et al. 2006). The function of vsg in Drosophila hema-
topoiesis or immune response has not been previously studied. We
tested the phenotypes of two P-element alleles, hypomorphic vsgEY0552
and complete loss-of-function vsgBG00708. Both alleles showed in-
creased plasmatocyte differentiation, detectible in early-to-middle
third-instar larvae, and by late third instar, the majority of cortical
cells expressed the plasmatocyte marker (P1, membrane red in Figure
2, C, C9, and H). In the mutants, the size of the MZ was decreased,
whereas the CZ became relatively enlarged (Figures 2H and 3B).
These results suggest that, similar to mammalian Endolin, Drosophila
Vsg has a blood-speciﬁc function: it controls homeostasis between MZ
and CZ and inhibits premature plasmatocyte maturation.
Shc is a conserved adaptor protein implicated in several signaling
pathways (RAS-MAPK, EGFR, PDGFR, TrkA) (Bonati et al. 2000; Hall-
berg et al. 1998; Lunghi et al. 2001; Luschnig et al. 2000). In humans, Shc
is highly enriched in primary acute myeloid leukemia blasts (Bonati et al.
2000; Lunghi et al. 2001). In Drosophila, mutations in shc are semi-lethal
and sterile, but the function of the gene in hematopoiesis has not been
studied (Luschnig et al. 2000). We found that a viable P-element in-
sertion in the 59-UTR of shc led to premature plasmatocyte differenti-
ation seen in middle third-instar lymph glands (Figure 2, D and D9).
CG30415 encodes the least-conserved protein that we obtained in
our screen, and its function is not known. A P-element insertion into
the 39-UTR of CG30415 (CG30415EY04039) causes a strong increase in
plasmatocyte differentiation, leading to early disintegration of the
primary lymph gland lobes and overgrowth and differentiation of
the secondary lobes (Figure 2I).
l(2)gl encodes a component of the Par (partitioning defective) com-
plex and is required for asymmetric cell division and establishment of
epithelial cell polarity (Ohshiro et al. 2000; Peng et al. 2000). At the
end of the third instar, l(2)gl4/Df(2L)net62 larvae develop tumors in
the brain and imaginal discs (Mechler et al. 1985). These mutant larvae
do not enter pupation. We noticed that lymph glands also undergo
strong overgrowth, up to 20–30 times depending on the age of the
larva. To standardize our investigations, we analyzed the lymph gland
phenotypes of homozygous mutants, heterozygous siblings, and wild-
type larvae of the same age (see Materials and Methods). In the
mutants, the lymph gland enlargement was already seen after the
second molt in early third-instar larvae when the tumors in other
tissues were not apparent. The CZ of the gland was signiﬁcantly ex-
panded, but it showed more variation in size and differentiation than
other mutants (Figures 2, E, E9,a n dJ ,a n d3 C ) .T h el y m p hg l a n d si n
heterozygous l(2)gl4/+ larvae were also slightly enlarged (not shown).
Enhancers of the Zfrp8/+ phenotype
In our screen, we identiﬁed two enhancers of Zfrp8null/+ lymph
gland overgrowth: smo and mus304 in trans to Zfrp8null caused
substantial increase of the lymph gland size (more than four times
wild-type size). A similar phenotype was previously observed in
Zfrp8null/+; Cdc27 L7123/+ animals (Minakhina et al. 2007).
Smo is a 7-transmembrane G-like protein-coupled receptor, an
essential component of the Hh pathway known to control prohemo-
cyte homeostasis (Mandal et al. 2007; Tokusumi et al. 2010). The
homozygous smo3 phenotype could not been studied because of early
larval lethality. Heterozygous smo3/+ larvae did not show lymph gland
enlargement (data not shown). The study of this gene will have to be
done in combination with other pathway players and will provide
better understanding of the role of Hh signaling in hematopoiesis.
Mus304 is involved in the mitotic cell cycle, DNA repair, and the
DNA damage checkpoint (Bi et al. 2005; Boyd et al. 1981; Brodsky
et al. 2000). Both alleles tested, mus304D1 and mus304D3 in trans to
Zfrp8null, lead to lymph gland enlargement of up to four times that of
wild type. mus304D3 is a homozygous viable allele that shows sensi-
tivity to mutagens, defects in DNA repair, and telomere maintenance
(Bi et al. 2005; Boyd et al. 1981; Brodsky et al. 2000). About half (9 of
14 tested) of the mus304D3 animals show lymph gland enlargement
(Figure 4, B and C), which was often accompanied (6 of 9) by lamel-
locyte over-differentiation in one or both primary lobes (Figure 3, F
and F9). No consistent changes in medulla-cortex organization, plas-
matocyte, or crystal cell differentiation were observed (Figure 4, C and
D). The overgrowth and occasional lamellocyte differentiation may
reﬂect an immune reaction to increased numbers of cells dying from
unrepaired spontaneous DNA damage. In addition, some increase in
cell proliferation may result from the lack of a mitotic checkpoint.
Cdc27, a previously identiﬁed enhancer of Zfrp8null/+ lymph gland
overgrowth, also encodes a cell-cycle protein and regulates the spindle
checkpoint (Deak et al. 2003; Minakhina et al. 2007). Mutation in
Cdc27 (Cdc27L71123) caused a modest reduction in differentiation and
no visible change in growth (Figures 3E and 4B).
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development using conditional knockdown
No mutations were available for a large number of genes uncovered by
the Zfrp8-interacting deﬁciencies. To test their function in hemato-
poiesis, we obtained UAS-dsRNA (RNAi) lines (VDRC or TRiP; Table
2) for 30 genes from seven interacting regions. Using the hemocyte-
speciﬁc driver pxn-GAL4, we knocked down each gene in the CZ of
the lymph gland and assessed the resulting phenotypes. For about half
of the lines, we also utilized a general driver, tubulin (tub)-Gal4,a n d
dome-GAL4, a driver expressed in embryos, some larval tissues, and
highly expressed in most MZ cells. Few dome-positive cells are also
found in the CZ transition zone (Sinenko et al. 2009). This zone is
notably enlarged in Zfrp8null/+ lymph glands, and mitotically active
CZ prohemocytes are intermingled with dome-positive cells [see Fig-
ure 5Q and Minakhina et al. (2007)].
T h em a j o r i t yo ft h eR N A il i n e su s e di nt h i ss t u d yc a u s e dn oo r
a variable lymph gland phenotype when expressed under the control of
pxn-Gal4. For several genes, the strong effect of the knockdown in the
CZ correlated with the general function of the gene in cell metabolism
or cell survival. For instance, knockdown of RpL31 by pxn-GAL4
resulted in disintegration of the CZ and hemocyte death. General
knockdown of RpL31 by tub-GAL4 caused growth arrest and early larval
lethality. Similarly, CG3911 and Not1 RNAi expression both caused early
lethality when generally expressed (tub-GAL4) and showed vast reduc-
tion in numbers of CZ cells when driven by pxn-GAL4 (not shown).
We selected four lines that triggered reproducible changes in
lymph gland development and also modiﬁed the Zfrp8null/+ pheno-
type (Figure 5) for further study. CG30338 and metal response ele-
ment-binding transcription factor-1 (MTF-1) suppressed Zfrp8null/+
overgrowth (Figure 5, Q–S), whereas knockdown of imaginal disc
growth factor 5 (Idgf5)a n dno-poles (nopo) enhanced the overgrowth
and led to premature primary lobe disintegration in late third-instar
larvae (Figure 5, T–V). Individual knockdown of each gene caused
distinct abnormalities in lymph gland development.
CG30338 encodes an uncharacterized conserved protein, a putative
ubiquitin-conjugating enzyme with DUF1115 and RWD domains
(Flybase annotation; Tweedie et al. 2009). Animals with general de-
pletion of CG30338 (tub-GAL4) survived until adulthood. The larval
lymph glands were smaller and contained increased numbers of plas-
matocytes and crystal cells (Figure 5B). When CG30338 was knocked
down in CZ by pxn-GAL4 or in MZ by dome-GAL4, no increase in
differentiation was observed. Interestingly, half of the dome-GAL4,
UAS-CG30338 RNAi animals showed fewer differentiated cells within
the lymph gland CZ than controls (Figure 5, F, G, K, and L). When
CG30338 was knocked down by dome-GAL4 in Zfrp8null /+ larvae, the
lymph glands appeared smaller than in Zfrp8null /+ animals and
showed similar levels of differentiation as the driver control (dome-
GAL4, UAS-cd8GFP; Figure 5, K, Q, and R). Thus, CG30338 appears
to control hemocyte maturation.
MTF-1 encodes a zinc ﬁnger protein that is conserved from insects
to mammals. In response to heavy metals, it activates a set of metal-
lothionine genes (Egli et al. 2003; Zhang et al. 2001). Knockdown of
the gene by tub-GAL4 affected larval growth and led to lethality
during the third instar. The lymph glands of these ailing larvae were
Figure 3 Changes in MZ-CZ organization in mutant
lymph glands. Confocal projections of late third-
instar lymph glands of wild type (A), vsgEY05552 (B)
homozygous mutants, and l(2)gl4 Df(2L)net62 (C).
The relative size of the CZ (anti-Pxn, membrane-cy-
toplasmic, red) in both mutants is increased, whereas
the MZ (Pxn-negative) size is decreased. Severe re-
duction of the MZ is also seen in early middle third-
instar noponull lymph glands (G, G9) compared with
wild-type lymph glands at the same stage (D). In
Cdc27L7123 and mus304D3 mutants (E, F) the relative
sizes of MZ and CZ are not signiﬁcantly changed.
Staining with phalloidin (green) shows the burst of
lamellocytes in cross-sections through the inner
lymph gland layers (F9,G 9) in one lobe of mus304D3.
Yellow dotted line separates MZ and CZ in (F9,G 9).
PSCs are stained with anti-Antp (nuclear red). DNA is
shown in blue. Scale bars are 10 mm.
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did not alter larval growth and viability. The lymph glands of these
larvae showed an increase in size (from 1.2 to 1.7 of wild-type size)
and relatively low levels of differentiation (Figure 5, H, M, and S). In
all 12 pxn-GAL4, UAS-MTF-1-RNAi lymph glands, we observed very
few differentiated plasmatocytes,s u g g e s t i n gt h a tM T F - 1m a ys p e c i ﬁcally
regulate plasmatocyte differentiation during normal hematopoiesis.
Idgf5 has chitinase and growth factor activity and is found in the
larval hemolymph (Karlsson et al. 2004; Kawamura et al. 1999), but its
role in hematopoiesis, wound healing, and immune response is un-
clear. When Idgf5 RNAi was driven by tub-GAL4 or dome-GAL4,t h e
lymph gland was 2 times enlarged and the number of crystal cells
was strongly increased (Figure 5, C and N). Knockdown of the gene at
later stages of hemocyte development (pxn-GAL4) did not increase the
number of crystal cells; rather, there were fewer differentiated hemo-
cytes than in controls, and in the same glands, the MZ was visibly
smaller (Figure 5I). These results suggest that Idgf5 may function early
in nondifferentiated hemocytes to regulate their fate. The expression
of Idgf5 RNAi under the control of dome-Gal4 resulted in strong
enhancement of the Zfrp8null /+ phenotype with increase in the size
of the MZ and transition zone (green in Figure 5T). Whether the
change of hemocyte fate can cause an overgrowth in sensitized
Zfrp8null/+ lymph glands remains unclear.
Nopo is a maternal effect cell-cycle regulator and encodes an E3
ubiquitin ligase (Merkle et al. 2009). Knockdown of the gene by three
different drivers leads to three different lymph gland phenotypes.
General knockdown with tub-GAL4 caused increase in differentiation
and premature disintegration of the primary lobes (Figure 5, D and E).
S i m i l a rt ow h a ti so b s e r v e dw i t hIdgf5 RNAi, expression of nopo RNAi
in CZ (pxn-GAL4)c a u s e dad e c r e a s eo ft h eM Zi nl a t et h i r d - i n s t a r
lymph glands without a severe increase in differentiation. When the
gene was downregulated in the MZ (dome-GAL4) ,t h eM Zw a sn o t
diminished but the medulla-cortex spatial organization was altered. The
gland became more spherical in shape, and the cortical zone covered
t h es u r f a c eo ft h ee n t i r eg l a n di n s t e a do ff o r m i n gad i s t a lp e t a l - s h a p e d
structure (Figure 5, N–P). Knockdown of nopo by dome-GAL4 in
combination with loss of one copy of Zfrp8 led to gland overgrowth,
followed by disintegration of the primary lobes and premature differ-
entiation of cells in the secondary lobe (Figure 5, U and V).
General knockdown of the gene caused great reduction in larval
viability, whereas existing nopo mutations are viable and sterile (Merkle
et al. 2009). We analyzed the lymph gland phenotypes of two mutant
alleles, nopoEXC142 and nopo Z1447.I nnopoEXC142, part of the 59-UTR
and the exons encoding amino acids 1–181 are deleted, and it is
therefore considered a null allele; nopoZ1447 is an E11K missense mu-
tation (Merkle et al. 2009). Lymph gland development in both mu-
tant alleles was similar. The primary lobes were 3–5 times enlarged
and had substantially increased numbers of plasmatocytes and crys-
tal cells (Figure 6, B and C). The size of the MZ was greatly reduced
(Figures 3, G and G9, and 6B). In second- and early third-instar larvae,
the MZ was represented by a narrow strip of cells adjacent to the
pericardial cells along the dorsal vessel (Figure 3G9), and during the
third-instar larval stage, it was barely half the size of the wild-type MZ
(Figure 6B). The mutants also showed an increase in crystal cell
numbers. To test if the increase in mature crystal cells (PPO-positive)
correlates with an increase in crystal-cell precursors, we stained the
wild-type and mutant lymph glands for the early crystal cell marker
Lz. In wild type, Lz-positive cells were relatively densely packed in the
CZ of middle third-instar lymph glands. In nopo mutants of the same
age, the CZ was greatly enlarged, and Lz-positive cells were found in
a similar density all over the CZ (Figure 6, D–E9). The increase in
mature crystal cells in nopo mutants correlated with CZ enlargement
and overall early blood cell maturation within the CZ (Figure 6B).
Mutant and knockdown phenotypes suggest that nopo controls ho-
meostasis between the hematopoietic precursors in the MZ, and the
prohemocytes and mature blood cells in the CZ.
DISCUSSION
Analysis of Zfrp8 mutant clones in the lymph gland show that it is
required in HSCs but is dispensable at later stages of hemocyte
proliferation or differentiation. But Zfrp8 mutants have vast lymph
gland overgrowth (Minakhina et al. 2007; Minakhina and Steward
2010). In the mutant lymph glands, all hemocytes rapidly proceed
to the stage of differentiation corresponding to wild-type CZ prohe-
mocytes, the most mitotically active stage during hemocyte develop-
ment (Jung et al. 2005; Krzemien et al. 2010; Minakhina and Steward
2010). Therefore, it is the loss of HSCs in the mutant animals that
ultimately leads to lymph gland overgrowth and severe change in
hemocyte homeostasis. Interestingly, the loss of one copy of the gene
also affects hemocyte development, leading to noticeable lymph gland
enlargement (Minakhina et al. 2007). In our previous screen for can-
didate modiﬁers of Zfrp8null/+ lymph gland overgrowth, we identiﬁed
two cell-cycle regulators and one novel gene, pnr, required for plas-
matocyte differentiation (Minakhina et al. 2007, 2011). Hence, we
hypothesized that two major groups of factors contribute to the Zfrp8
lymph gland phenotype, direct regulators of the cell cycle, and factors
controlling hemocyte differentiation.
Figure 4 Lymph gland differentiation in mus304 and cdc27 mutants
Confocal cross-sections (A, C) and projections (B, D) of wild type (A),
Cdc27L7123 (B), and mus304D3 (C, D) middle-late third-instar larval
lymph glands. Mutant lymph glands show some delay in plasmatocyte
differentiation (P1, membrane marker, red). mus304D3 lymph glands
show variations in size and differentiation (C, D). PSCs are stained with
anti-Antp (nuclear red). DNA is shown in blue. (A, C) The primary lobes
are outlined by white dotted line, and the border between MZ and CZ
is shown by yellow dotted line; staining with phalloidin (green in A, C)
allows detection of lamellocytes. Scale bars are 10 mm.
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designed to detect regulators of cellular immune response, hemocyte
activation, and melanotic mass formation (Avet-Rochex et al. 2010;
Milchanowski et al. 2004; Rodriguez et al. 1996; Zettervall et al. 2004).
The majority of the genes identiﬁed in these screens regulate lamello-
cyte and crystal cell development. Our present genetic screen yielded
a number of new genes involved in hemocyte differentiation, par-
ticularly of plasmatocytes. The lack of signiﬁcant overlap between
all screens can be explained by the difference in screen designs. It
also suggests that many hematopoietic genes have not been iden-
tiﬁed so far. For instance, a recent RNAi screen by Avet-Rochex
et al. (2010) targeting about 10% of Drosophila genes identiﬁed 59
hematopoietic factors, 55 of which were not previously linked to
blood cell development.
In our screen, we identiﬁed 10 deﬁciencies that had dominant
lymph gland phenotypes both in a wild-type background and in trans
to Zfrp8null and 21 deﬁciencies that modiﬁed the Zfrp8null/+ pheno-
type but did not show lymph gland abnormalities in a wild-type
background. We tested 15% of the genes uncovered by 9 modifying
deﬁciencies and identiﬁed 16 suppressors and enhancers of Zfrp8null/+
lymph gland overgrowth. For 9 of these genes, we showed a new role
in the regulation of blood cell development.
Our screen also suggested that the number of uncharacterized
genes regulating different aspects of hematopoiesis is much larger than
the number of genes identiﬁed so far. This conclusion is supported by
the following observation: we characterized half of interacting deﬁ-
ciencies and many of them uncover two or more modifying genes. For
instance, in two chromosomal regions (30C5 and 67A2–D12), we
found four dominant suppressors, pelo, hoip, shc, and vsg.O t h e r
two modifying deﬁciencies, Df(3L)W10 and DF(2L)net-PMF,c o n -
tained both enhancers and suppressors (see Table 1).
Of the four enhancers identiﬁed in the screen, two, mus304 and
nopo, function in the DNA-damage response and cell-cycle regulation.
A previously identiﬁed enhancer of Zfrp8null/+ lymph gland overgrowth,
Figure 5 Knockdown phenotypes of Zfrp8 modiﬁers. Confocal projections of lymph glands obtained from the crosses of the three drivers [tub-
GAL4 (A–E); pxn-GAL4,2XUAS-nlsGFP (CZ cells, nuclear green, F–J), and dome-GAL4, UAS-cd8GFP (MZ cells, membrane green, K–P)] to UAS-
RNAi lines of CG30338 (B, G, L, R), MTF-1 (H, M, S), Idlg5 (C, I, N, T), and nopo (D, E, J, O, P, U, V). Drivers crossed with wild type (A, F, K) show
normal MZ-CZ organization and hemocyte differentiation. (Q) dome-GAL4, UAS-cd8GFP combined with heterozygous Zfrp8null shows lymph
gland enlargement, similar to that of Zfrp8null/+, and increase in dome-positive cells intermingled with CZ prohemocytes. The lymph gland
overgrowth is suppressed when CG30338 (R) or MTF-1 (S) are knocked down in MZ, whereas overgrowth is enhanced when Idgf5 (T) or nopo (V)
are depleted. nopo knockdown in trans to Zfrp8null/+ also causes disintegration of primary lobes in late third-instar larvae (V). Primary lobes
(outlined by white dotted line) are identiﬁed by their anterior position and presence of PSC (anti-Antp, nuclear red). Secondary lobes (SL) show
excessive growth and differentiation in most nopo knockdown lymph glands (E, J, U, V). Plasmatocytes are stained with P1 antibody (membrane,
red) and crystal cells with anti-PPO2 (cytoplasmic, pink). DNA is shown in blue. Scale bar is 10 mm.
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checkpoint (Deak et al. 2003; Minakhina et al. 2007). Analysis of
homozygous mutant phenotypes of individual genes has shown that
each of the three genes triggered different changes in lymph gland
development. Mutation in Cdc27 caused modest decrease in growth
and differentiation (Figures 3E and 4B), and mus304 prompted
moderate overgrowth and high incidence of lamellocyte differentia-
tion in one or more lobes (Figures 3, F and F9, and 4, C and D).
Mutations in nopo and nopo gene knockdown had complex effects
on lymph gland development, including noticeable overgrowth, MZ
reduction, and increase in crystal cells (Figures 5 and 6). None of the
three genes had a dominant phenotype, and all of them enhanced
Zfrp8null/+ lymph gland overgrowth. These genes may function to-
gether with Zfrp8 in regulating HSC division. Alternatively, their
dominant effects on cell-cycle timing may become only evident in
the Zfrp8null/+ background, in which the population of mitotically
active CZ prohemocytes is increased.
The majority of dominant modiﬁers identiﬁed in the screen
suppressed the Zfrp8null/+ lymph gland overgrowth. We analyzed
homozygous phenotypes of ﬁve of the nine suppressing genes, and
all represented different molecular pathways. With the exception of
l(2)gl, they all had a similar effect on hemocyte differentiation. Ho-
mozygous loss-of-function mutants induced early plasmatocyte differ-
entiation and changed the balance between the CZ and MZ (Figures 2
and 3). Three of the genes, AdgfA, vsg,a n dShc, are highly conserved
across species, but only AdgfA was previously reported to function in
Drosophila hematopoiesis (Dolezal et al. 2005). Interestingly, human
homologs of both Vsg and Shc are differentially expressed in hema-
topoietic progenitors and leukemic cells (Chan et al. 2001; Forde et al.
2007; Fukuda et al. 2011; Lunghi et al. 2001). The mammalian Vsg
ortholog, endolyn (CD164), regulates the interaction of hematopoietic
stem and precursor cells with the niche and their adhesion and mi-
gration (Forde et al. 2007). Drosophila Vsg is required for homeostasis
between precursor cells and differentiated hemocytes, a process that
also depends on niche signaling.
Using RNAi-mediated conditional gene knockdown, we identiﬁed
four new genes functioning in Drosophila hematopoiesis. Three of
them may have similar functions in vertebrates. We found that
MTF-1 is required for plasmatocyte development in the Drosophila
lymph gland, whereas its mouse homolog is known to play a critical
role in lymphocyte development (Wang et al. 2004). The second gene,
nopo, affects early embryonic development (Merkle et al. 2009), and in
our experiments, it shows a striking lymph gland phenotype but does
not affect other somatic tissues. It has been suggested that lack of
Nopo may change the timing of the S-M transition and lead to acen-
trosomal or mis-oriented spindles (Merkle et al. 2009). The develop-
ment of lymph glands may be particularly sensitive to these defects.
However Nopo may also function in ubiquitination of non-cell-cycle–
related, blood-cell–speciﬁc targets. Nopo is one of about 130 E3 ubiq-
uitin ligases encoded in the Drosophila genome (Merkle et al. 2009),
and its mammalian orthologs, such as c-Cbl, Fbw7, Triad1, and FLRF
(Rnf41), are implicated in normal and malignant hematopoiesis (Jing
et al. 2008; Kitagawa et al. 2009; Marteijn et al. 2009; Rathinam et al.
2008; Reavie et al. 2010). The third conserved gene, CG30338,e n c o d e s
a predicted ubiquitin-conjugating enzyme, another component of
ubiquitination pathway. It is the least-studied gene, and its interesting
hematopoietic phenotype in ﬂies and the conserved structure of the
protein across species warrants future investigation.
Most mutations identiﬁed in this screen caused distinct abnor-
malities in hemocyte differentiation, but none resulted in complete
loss or enlargement of the MZ, suggesting that early stages of
hematopoiesis were least affected. Given that Zfrp8 is required already
in the embryo in HSCs and that the overgrowth is a consequence of
this early lymph gland abnormality, it is not surprising that we
obtained an array of genes functioning at different points of
hematopoiesis later in development, affecting a number of conserved
molecular pathways. Our results show that the similarities between
mechanisms of regulation of hematopoiesis in ﬂies and mammals
extend beyond transcriptional regulation, and hence, Drosophila
serves as an excellent model for identiﬁcation and study of genes
functioning in growth control, cell cycle, and cell differentiation in
hematopoiesis.
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Figure 6 nopo affects lymph gland growth and hemo-
cyte differentiation. Primary lobes are outlined with
white dotted line. Crystal cell (anti-PPO2, pink) and plas-
matocyte maturation (P1, membrane, red) are increased
in middle third-instar (B) and late third-instar (C) noponull
lymph glands compared with that in wild type (A). Sec-
ondary lobes (SL) do not express differentiation markers.
Confocal cross-sections through the inner cell layers (A,
B) show drastic decrease in mutant MZ size (yellow dot-
ted line). Staining with phalloidin (green) shows cell
shape. Staining for Lozenge (Lz), an early crystal cell
marker (D–E9, green/white), shows greater than 5 times
increase in number of crystal cells in noponull lymph
gland lobes (E, E9) compared with that in wild type (D,
D9).
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